- Evolving Treatment Landscape: CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
- Referral timing and treatment sequencing
- Bridging therapy
- Toxicity management
- CAR T-Cell Therapy in Early Relapsed/Refractory Multiple Myeloma: Translating Data to Clinical Practice
- CAR-T place in therapy
- Treatment sequencing
- Best practices
- Interactive live Q&A throughout the entire event
OncLive® State of the Science Summit® CAR-T Clinical Strategy
The Pierre, A Taj Hotel, New York
2 E 61st St, New York, NY 10065
United States
Wednesday, October 21, 2026
6:00 PM-8:30 PM EDT
Hybrid Event
Registration is complimentary. In-Person attendance includes dinner, drinks, & entry into a raffle to win a snappy gift of your choosing.
Event Chair
Marco Davila, MD, PhD
Roswell Park Comprehensive Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit® (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary and includes dinner, drinks, and entry into a raffle for a chance to win a gift of your choice.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831